Utah Medical Products, Inc.
UTMD
Market Cap$187.75M
Close$
$125.55
120.6% upside
Current Fair Value
120.6% upsideUndervalued by 120.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $187.75 Million |
|---|---|
| Enterprise Value | $105.39 Million |
| Dividend Yield | $1.215 (2.10207612456747%) |
| Earnings per Share | $3.96 |
| Beta | 0.28 |
| Outstanding Shares | 3,310,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 14.76 |
|---|---|
| PEG | -63.83 |
| Price to Sales | 5.17 |
| Price to Book Ratio | 1.63 |
| Enterprise Value to Revenue | 2.68 |
| Enterprise Value to EBIT | 7.16 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Utah Medical Products, Inc.
CEO: Kevin Cornwell Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hund...